Angiotensin II receptor subtype I antagonism and diastolic cardiac filling in man.
Shiels
P
P
Lim
P O
PO
Leary
A C
AC
McMahon
A D
AD
MacDonald
T M
TM
D000328:Adult; D000804:Angiotensin II / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D002317:Cardiovascular Agents / Q000627:therapeutic use; D018592:Cross-Over Studies; D003971:Diastole / Q000187:drug effects / Q000502:physiology; D004311:Double-Blind Method; D004452:Echocardiography; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013777:Tetrazoles / Q000627:therapeutic use; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068756:Valsartan
D057911:Angiotensin Receptor Antagonists; D002317:Cardiovascular Agents; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013777:Tetrazoles; D000804:Angiotensin II; D000068756:Valsartan; D014633:Valine